Author： Strumberg Dirk
Publisher： Informa Healthcare
ISSN： 1465-6566
Source： Expert Opinion on Pharmacotherapy, Vol.13, Iss.3, 2012-02, pp. : 407-419
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Sorafenib: In Advanced Renal Cancer
By McKeage Kate Wagstaff Antona J.
Drugs, Vol. 67, Iss. 3, 2007-01 ,pp. :
Access to resources
Recommend
Sorafenib enhances HRQOL in renal cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 533, 2007-01 ,pp. :
Sorafenib on TARGET in advanced renal cancer
Inpharma, Vol. 1, Iss. 1597, 2007-01 ,pp. :
Sorafenib suspends progression in renal cancer
Inpharma, Vol. 1, Iss. 1490, 2005-01 ,pp. :
Sorafenib in Advanced Renal Cancer: A Viewpoint by Michael Staehler
Drugs, Vol. 67, Iss. 3, 2007-01 ,pp. :